Retinoid X Receptor : Cellular and Biochemical Roles of Nuclear Receptor with a Focus on Neuropathological Involvement
© 2021. The Author(s)..
Retinoid X receptors (RXRs) present a subgroup of the nuclear receptor superfamily with particularly high evolutionary conservation of ligand binding domain. The receptor exists in α, β, and γ isotypes that form homo-/heterodimeric complexes with other permissive and non-permissive receptors. While research has identified the biochemical roles of several nuclear receptor family members, the roles of RXRs in various neurological disorders remain relatively under-investigated. RXR acts as ligand-regulated transcription factor, modulating the expression of genes that plays a critical role in mediating several developmental, metabolic, and biochemical processes. Cumulative evidence indicates that abnormal RXR signalling affects neuronal stress and neuroinflammatory networks in several neuropathological conditions. Protective effects of targeting RXRs through pharmacological ligands have been established in various cell and animal models of neuronal injury including Alzheimer disease, Parkinson disease, glaucoma, multiple sclerosis, and stroke. This review summarises the existing knowledge about the roles of RXR, its interacting partners, and ligands in CNS disorders. Future research will determine the importance of structural and functional heterogeneity amongst various RXR isotypes as well as elucidate functional links between RXR homo- or heterodimers and specific physiological conditions to increase drug targeting efficiency in pathological conditions.
| Errataetall: | |
|---|---|
| Medienart: |
E-Artikel |
| Erscheinungsjahr: |
2022 |
|---|---|
| Erschienen: |
2022 |
| Enthalten in: |
Zur Gesamtaufnahme - volume:59 |
|---|---|
| Enthalten in: |
Molecular neurobiology - 59(2022), 4 vom: 11. Apr., Seite 2027-2050 |
| Sprache: |
Englisch |
|---|
| Beteiligte Personen: |
Sharma, Samridhi [VerfasserIn] |
|---|
| Links: |
|---|
| Anmerkungen: |
Date Completed 20.04.2022 Date Revised 16.07.2022 published: Print-Electronic ErratumIn: Mol Neurobiol. 2022 Mar 12;:. - PMID 35278210 Citation Status MEDLINE |
|---|
| doi: |
10.1007/s12035-021-02709-y |
|---|
| funding: |
|
|---|---|
| Förderinstitution / Projekttitel: |
|
| PPN (Katalog-ID): |
NLM335503799 |
|---|
| LEADER | 01000naa a22002652 4500 | ||
|---|---|---|---|
| 001 | NLM335503799 | ||
| 003 | DE-627 | ||
| 005 | 20231225230010.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 231225s2022 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1007/s12035-021-02709-y |2 doi | |
| 028 | 5 | 2 | |a pubmed24n1118.xml |
| 035 | |a (DE-627)NLM335503799 | ||
| 035 | |a (NLM)35015251 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 100 | 1 | |a Sharma, Samridhi |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a Retinoid X Receptor |b Cellular and Biochemical Roles of Nuclear Receptor with a Focus on Neuropathological Involvement |
| 264 | 1 | |c 2022 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a ƒaComputermedien |b c |2 rdamedia | ||
| 338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Date Completed 20.04.2022 | ||
| 500 | |a Date Revised 16.07.2022 | ||
| 500 | |a published: Print-Electronic | ||
| 500 | |a ErratumIn: Mol Neurobiol. 2022 Mar 12;:. - PMID 35278210 | ||
| 500 | |a Citation Status MEDLINE | ||
| 520 | |a © 2021. The Author(s). | ||
| 520 | |a Retinoid X receptors (RXRs) present a subgroup of the nuclear receptor superfamily with particularly high evolutionary conservation of ligand binding domain. The receptor exists in α, β, and γ isotypes that form homo-/heterodimeric complexes with other permissive and non-permissive receptors. While research has identified the biochemical roles of several nuclear receptor family members, the roles of RXRs in various neurological disorders remain relatively under-investigated. RXR acts as ligand-regulated transcription factor, modulating the expression of genes that plays a critical role in mediating several developmental, metabolic, and biochemical processes. Cumulative evidence indicates that abnormal RXR signalling affects neuronal stress and neuroinflammatory networks in several neuropathological conditions. Protective effects of targeting RXRs through pharmacological ligands have been established in various cell and animal models of neuronal injury including Alzheimer disease, Parkinson disease, glaucoma, multiple sclerosis, and stroke. This review summarises the existing knowledge about the roles of RXR, its interacting partners, and ligands in CNS disorders. Future research will determine the importance of structural and functional heterogeneity amongst various RXR isotypes as well as elucidate functional links between RXR homo- or heterodimers and specific physiological conditions to increase drug targeting efficiency in pathological conditions | ||
| 650 | 4 | |a Journal Article | |
| 650 | 4 | |a Review | |
| 650 | 4 | |a Alzheimer disease | |
| 650 | 4 | |a Bexarotene | |
| 650 | 4 | |a Endogenous ligands | |
| 650 | 4 | |a Exogenous ligands | |
| 650 | 4 | |a Glaucoma | |
| 650 | 4 | |a Glucose metabolism | |
| 650 | 4 | |a Heterodimerisation | |
| 650 | 4 | |a Lipid X receptor (LXR) | |
| 650 | 4 | |a Lipid metabolism ligand | |
| 650 | 4 | |a Multiple sclerosis | |
| 650 | 4 | |a Neuroinflammation | |
| 650 | 4 | |a Neuronal stress | |
| 650 | 4 | |a Neuroprotection | |
| 650 | 4 | |a Nuclear receptor-related 1 (Nurr1) | |
| 650 | 4 | |a Nuclear receptors | |
| 650 | 4 | |a Parkinson disease | |
| 650 | 4 | |a Peroxisome proliferator-activated receptor (PPAR) | |
| 650 | 4 | |a Retinoid X receptor (RXR) | |
| 650 | 4 | |a Stroke | |
| 650 | 7 | |a Ligands |2 NLM | |
| 650 | 7 | |a Receptors, Cytoplasmic and Nuclear |2 NLM | |
| 650 | 7 | |a Retinoid X Receptors |2 NLM | |
| 700 | 1 | |a Shen, Ting |e verfasserin |4 aut | |
| 700 | 1 | |a Chitranshi, Nitin |e verfasserin |4 aut | |
| 700 | 1 | |a Gupta, Veer |e verfasserin |4 aut | |
| 700 | 1 | |a Basavarajappa, Devaraj |e verfasserin |4 aut | |
| 700 | 1 | |a Sarkar, Soumalya |e verfasserin |4 aut | |
| 700 | 1 | |a Mirzaei, Mehdi |e verfasserin |4 aut | |
| 700 | 1 | |a You, Yuyi |e verfasserin |4 aut | |
| 700 | 1 | |a Krezel, Wojciech |e verfasserin |4 aut | |
| 700 | 1 | |a Graham, Stuart L |e verfasserin |4 aut | |
| 700 | 1 | |a Gupta, Vivek |e verfasserin |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t Molecular neurobiology |d 1990 |g 59(2022), 4 vom: 11. Apr., Seite 2027-2050 |w (DE-627)NLM012626961 |x 1559-1182 |7 nnns |
| 773 | 1 | 8 | |g volume:59 |g year:2022 |g number:4 |g day:11 |g month:04 |g pages:2027-2050 |
| 856 | 4 | 0 | |u http://dx.doi.org/10.1007/s12035-021-02709-y |3 Volltext |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a GBV_NLM | ||
| 951 | |a AR | ||
| 952 | |d 59 |j 2022 |e 4 |b 11 |c 04 |h 2027-2050 | ||